Wei Yuan

12.0k total citations
106 papers, 2.9k citations indexed

About

Wei Yuan is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Wei Yuan has authored 106 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 31 papers in Immunology and 23 papers in Cancer Research. Recurrent topics in Wei Yuan's work include Prostate Cancer Treatment and Research (14 papers), Immune Cell Function and Interaction (12 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Wei Yuan is often cited by papers focused on Prostate Cancer Treatment and Research (14 papers), Immune Cell Function and Interaction (12 papers) and Cancer Immunotherapy and Biomarkers (12 papers). Wei Yuan collaborates with scholars based in China, United Kingdom and United States. Wei Yuan's co-authors include Dong‐Ming Kuang, Limin Zheng, Xiang‐Ming Lao, Dong‐Ping Chen, Christos Xiao, Fang‐Zhu Ouyang, Ruixian Liu, Minmin Chen, Jie Ma and Qiyi Zhao and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Wei Yuan

96 papers receiving 2.8k citations

Peers

Wei Yuan
John Sarantopoulos United States
Todd VanArsdale United States
Jirun Peng China
Cosmo Damiano Gadaleta Italy
Joe Yeong Singapore
Karim A. Benhadji United States
Yoshinori Ino Japan
Su Yin Lim Australia
Minji Jo United States
Romain Boidot France
John Sarantopoulos United States
Wei Yuan
Citations per year, relative to Wei Yuan Wei Yuan (= 1×) peers John Sarantopoulos

Countries citing papers authored by Wei Yuan

Since Specialization
Citations

This map shows the geographic impact of Wei Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Yuan more than expected).

Fields of papers citing papers by Wei Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Yuan. The network helps show where Wei Yuan may publish in the future.

Co-authorship network of co-authors of Wei Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Yuan. A scholar is included among the top collaborators of Wei Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Yuan. Wei Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Jia, Runting Yin, Yuan Chao Xue, et al.. (2025). Advances in the study of epithelial mesenchymal transition in cancer progression: Role of miRNAs. Progress in Biophysics and Molecular Biology. 196. 69–90.
3.
Ma, Yingli, Xiaoya Ma, Liying Lu, et al.. (2025). Circulating catalysis nanocomposites for photodynamic and starvation treatment via long-persistent regulation of tumor hypoxia. Colloids and Surfaces B Biointerfaces. 258. 115227–115227.
4.
Wang, Xijun, Yiran Wang, Rui Guo, et al.. (2025). Targeted depletion of intratumoral bacteria using PEGylated metronidazole to augment cancer treatment efficacy. Biomaterials. 327. 123772–123772.
5.
Francis, Jeffrey C., Alistair G. Rust, Jian Ning, et al.. (2024). Identification of genes that promote PI3K pathway activation and prostate tumour formation. Oncogene. 43(24). 1824–1835. 3 indexed citations
6.
Tao, Ran, Wei Yuan, Fang Xiao, et al.. (2023). Fibrinogen-like protein 2 promotes proinflammatory macrophage polarization and mitochondrial dysfunction in liver fibrosis. International Immunopharmacology. 117. 109631–109631. 11 indexed citations
7.
Ma, Jiangwen, et al.. (2023). Pulmonary human immune responses in a humanized immune mouse model during influenza virus infection. 1(1). 100009–100009. 5 indexed citations
8.
9.
Wang, Xuyan, Wei Yuan, Bo Hu, et al.. (2022). c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses. Signal Transduction and Targeted Therapy. 7(1). 105–105. 41 indexed citations
10.
Baratchian, Mehdi, Ritika Tiwari, Sirvan Khalighi, et al.. (2022). H3K9 methylation drives resistance to androgen receptor–antagonist therapy in prostate cancer. Proceedings of the National Academy of Sciences. 119(21). e2114324119–e2114324119. 35 indexed citations
11.
Chen, Dong‐Ping, Shi‐Xun Lu, Jinbin Chen, et al.. (2022). PIM2 Expression Induced by Proinflammatory Macrophages Suppresses Immunotherapy Efficacy in Hepatocellular Carcinoma. Cancer Research. 82(18). 3307–3320. 12 indexed citations
12.
Baek, GuemHee, Suzanne Carreira, Wei Yuan, et al.. (2022). Targeting radioresistance and replication fork stability in prostate cancer. JCI Insight. 7(9). 7 indexed citations
13.
Sheehan, Beshara, Antje Neeb, Lorenzo Buroni, et al.. (2022). Prostate-Specific Membrane Antigen Expression and Response to DNA Damaging Agents in Prostate Cancer. Clinical Cancer Research. 28(14). 3104–3115. 22 indexed citations
14.
Yuan, Wei, Lifeng Li, Zhibo Shen, et al.. (2022). Immunogenomic-Based Analysis of Hierarchical Clustering of Diffuse Large Cell Lymphoma. Journal of Immunology Research. 2022. 1–16. 4 indexed citations
15.
Yuan, Wei, Xiang‐Ming Lao, Dong‐Ping Chen, et al.. (2020). B cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis. Science Advances. 6(37). 33 indexed citations
16.
Li, Shangze, Ka-wing Fong, Galina Gritsina, et al.. (2019). Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. Cancer Research. 79(10). 2580–2592. 92 indexed citations
17.
Yuan, Wei, et al.. (2017). Risk Factors and Outcomes of Acute Kidney Injury in Patients With Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. The American Journal of the Medical Sciences. 353(5). 452–458. 10 indexed citations
18.
Chen, Minmin, Christos Xiao, Xiang‐Ming Lao, et al.. (2016). Polarization of Tissue-Resident TFH-Like Cells in Human Hepatoma Bridges Innate Monocyte Inflammation and M2b Macrophage Polarization. Cancer Discovery. 6(10). 1182–1195. 64 indexed citations
19.
Xiao, Christos, Xiang‐Ming Lao, Minmin Chen, et al.. (2016). PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression. Cancer Discovery. 6(5). 546–559. 268 indexed citations
20.
Kuang, Dong‐Ming, Christos Xiao, Qiyi Zhao, et al.. (2014). B7-H1–expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets. Journal of Clinical Investigation. 124(10). 4657–4667. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Sarantopoulos Breakdown of academic impact, for papers by Todd VanArsdale Breakdown of academic impact, for papers by Jirun Peng Breakdown of academic impact, for papers by Cosmo Damiano Gadaleta Breakdown of academic impact, for papers by Joe Yeong Breakdown of academic impact, for papers by Karim A. Benhadji Breakdown of academic impact, for papers by Yoshinori Ino Breakdown of academic impact, for papers by Su Yin Lim Breakdown of academic impact, for papers by Minji Jo Breakdown of academic impact, for papers by Romain Boidot
Rankless by CCL
2026